Novartis’ iptacopan gets EMA's orphan drug designation in IgAN

Novartis’ iptacopan gets EMA’s orphan drug designation in IgAN

Novartis secures orphan drug designation from EMA for iptacopan in IgAN.

The orphan drug status to iptacopan has been granted by the regulator after a recommendation from the Committee for Orphan Medicinal Products (COMP). Although considered to be a … Continue reading Novartis’ iptacopan gets EMA’s orphan drug designation in IgAN

Pharmaceutical Business review

Copy and paste this URL into your WordPress site to embed

<blockquote class="wp-embedded-content"><a href="https://www.pharmaceutical-business-review.com/news/novartis-iptacopan-ema-orphan-drug-designation-igan/">Novartis’ iptacopan gets EMA&#8217;s orphan drug designation in IgAN</a></blockquote>
<script type='text/javascript'>
<!--//--><![CDATA[//><!--
		/*! This file is auto-generated */
		!function(c,d){"use strict";var e=!1,n=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=d.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o<n.length;o++)n[o].style.display="none";for(o=0;o<s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3<(i=parseInt(t.value,10)))i=1e3;else if(~~i<200)i=200;r.height=i}if("link"===t.message)if(a=d.createElement("a"),i=d.createElement("a"),a.href=r.getAttribute("src"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),d.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(!n){n=!0;for(var e,t,r=-1!==navigator.appVersion.indexOf("MSIE 10"),a=!!navigator.userAgent.match(/Trident.*rv:11\./),i=d.querySelectorAll("iframe.wp-embedded-content"),s=0;s<i.length;s++){if(!(e=i[s]).getAttribute("data-secret"))t=Math.random().toString(36).substr(2,10),e.src+="#?secret="+t,e.setAttribute("data-secret",t);if(r||a)(t=e.cloneNode(!0)).removeAttribute("security"),e.parentNode.replaceChild(t,e)}}}}(window,document);
//--><!]]>
</script><iframe sandbox="allow-scripts" security="restricted" src="https://www.pharmaceutical-business-review.com/news/novartis-iptacopan-ema-orphan-drug-designation-igan/embed/" width="600" height="400" title="&#8220;Novartis’ iptacopan gets EMA&#8217;s orphan drug designation in IgAN&#8221; &#8212; Pharmaceutical Business review" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe>

Copy and paste this code into your site to embed